drugset / Trial / NCT00526253

To Assess Safety and Efficacy of Myoblast Implantation Into Myocardium Post Myocardial Infarction

NCT00526253 ↗

Phase 2/3 Unknown 170 enrolled Bioheart, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

This study injects a person's own stem cells into heart muscle tissue after a person has one or more heart attacks. The purpose of the study is whether the stem cells will improve a patient's heart performance.

Timeline

Start
2007-09
Primary completion
2019-02
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Comparator MyoCell™ Cell therapy 400 cells Other
Comparator MyoCell™ Cell therapy 800 cells Other